If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 62   2001   SUPPLEMENT 9

Articles

3 Introduction: Evaluating Clinical Trial Data From Schizophrenia Research. Carol A. Tamminga
[PDF]

5 Hypothesis and Hypothesis Testing in the Clinical Trial. Jeffrey A. Lieberman
[Abstract] [PDF]

11 Evaluating Characteristics of Patient Selection and Dropout Rates. Samuel J. Keith
[Abstract] [PDF]

17 Clinical Trial Design Issues in Schizophrenic Research. Daniel E. Casey
[Abstract] [PDF]

23 Evaluating Clinical Trial Data: Outcome Measures. Robert R. Conley
[Abstract] [PDF]

29 Dose Selection and Comparator Drugs in Schizophrenia Research. John M. Kane
[Abstract] [PDF]

35 The Statistical Comparison of Clinical Trials. Nina R. Schooler
[Abstract] [PDF]

40 Interpretations and Conclusions in the Clinical Trial. John P. Docherty
[Abstract] [PDF]

44 Concluding Discussion.
[PDF]

CME Section

46 Instructions and Posttest.
[PDF]

48 CME Registration and Evaluation.
[PDF]